GI
TGTX icon

GAMMA Investing’s TG Therapeutics TGTX Stock Holding History

GAMMA Investing’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$331K Buy
5,929
+789
+15% +$42.7K 0.01% 963
2026
Q2 		$282K Buy
5,140
+1,216
+31% +$49.8K 0.01% 1018
2026
Q1 		$130K Buy
3,924
+426
+12% +$12.7K 0.01% 1452
2025
Q4 		$104K Sell
3,498
-131
-4% -$4.28K 0.01% 1547
2025
Q3 		$131K Sell
3,629
-856
-19% -$28.2K 0.01% 1277
2025
Q2 		$161K Sell
4,485
-58
-1% -$2.16K 0.01% 1060
2025
Q1 		$179K Buy
4,543
+1,986
+78% +$66.8K 0.01% 820
2024
Q4 		$77K Buy
2,557
+2,171
+562% +$62.3K 0.01% 1308
2024
Q3 		$9.03K Buy
386
+327
+554% +$7.14K ﹤0.01% 2503
2024
Q2 		$1.05K Buy
59
+9
+18% +$144 ﹤0.01% 3046
2024
Q1 		$761 Hold
50
– – ﹤0.01% 3002
2023
Q4 		$812 Buy
+50
New +$581 ﹤0.01% 2849

Other funds holding TGTX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
AWM
Avaii Wealth Management Appleton, Wisconsin $348M AUM 25.11% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
NWMP
Noble Wealth Management PBC Greenwood Village, Colorado $223M AUM 7.64% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

GAMMA Investing's TGTX Position: Q3 2026 in Review

GAMMA Investing increased its TG Therapeutics (TGTX) stake by 15% in Q3 2026, buying an estimated $42.7K and bringing the position to 5,929 shares worth $331K. The position accounts for 0.01% of the portfolio, ranked #963.

GAMMA Investing first reported a position in TGTX in Q4 2023 and has held it in 12 quarters since. 12 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • GAMMA Investing held 5,929 shares of TG Therapeutics worth $331K as of Q3 2026.
  • GAMMA Investing bought 789 TG Therapeutics shares in Q3 2026, an estimated $42.7K.
  • TG Therapeutics made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #963 holding.
  • GAMMA Investing first reported a position in TG Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • 12 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.